Compare CPHC & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPHC | SRTS |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.9M | 65.5M |
| IPO Year | 2016 | 2016 |
| Metric | CPHC | SRTS |
|---|---|---|
| Price | $15.85 | $4.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 766.0 | ★ 37.7K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.77% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,227,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.14 | N/A |
| 52 Week Low | $14.49 | $3.03 |
| 52 Week High | $21.61 | $5.92 |
| Indicator | CPHC | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 59.32 | 42.58 |
| Support Level | $14.97 | $3.66 |
| Resistance Level | $15.95 | $4.60 |
| Average True Range (ATR) | 0.10 | 0.24 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 100.00 | 19.70 |
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the real estate development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.